{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:38:46Z","timestamp":1767713926240,"version":"3.48.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"The Sch\u00f6rling Foundation"},{"DOI":"10.13039\/501100003793","name":"Swedish Heart-Lung Foundation","doi-asserted-by":"publisher","award":["20220151"],"award-info":[{"award-number":["20220151"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Structural valve deterioration is an inherent limitation of bioprosthetic valves; however, the time it takes to develop varies depending on the valve model. The Sorin Soprano aortic bioprosthetic valve (Sorin Group\/LivaNova, Milan, Italy) lacks reported long-term results. This study aims to establish the long-term durability of this bioprosthetic valve in a nationwide cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All patients who had received the Soprano bioprosthesis during aortic valve replacement in Sweden between 2005 and 2013 were included in the study. Patient characteristics, outcomes, and echocardiographic data were collected using national registries and electronic medical records. Standardized guidelines were used to assess echocardiographic data for the presence of severe structural valve deterioration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1054 patients (mean age 73.3 years) were included, with 14.0% being \u226465 years at surgery. The Soprano bioprosthesis represented 9.5% of all implanted bioprostheses. During a mean follow-up of 8.6\u2009\u00b1\u20094.5 years, 206 patients (19.5%) developed severe structural valve deterioration. The cumulative incidence of severe structural valve deterioration at 1, 5, 7, 10, and 15 years was 0.5%, 3.1%, 7.4%, 13.7%, and 22.1%, respectively, in the overall population. The cumulative incidence of structural valve deterioration-related reinterventions at 1, 5, 7, 10, and 15 years was 0%, 0.9%, 3.0%, 7.2%, and 11.5%, respectively. The 30-day mortality rate was 3.8%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The Soprano bioprosthesis demonstrates high long-term rates of severe structural valve deterioration and deterioration-related reinterventions. These findings suggest the need for increased clinical vigilance and for more frequent echocardiographic monitoring in patients having received this bioprosthetic valve.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejcts\/ezaf469","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T12:49:02Z","timestamp":1766234942000},"source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Durability of the Sorin Soprano Aortic Bioprosthetic Valve\u2014A Swedish Nationwide Study"],"prefix":"10.1093","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6542-4865","authenticated-orcid":false,"given":"Gustav","family":"H\u00f6kfelt","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, Karolinska University Hospital , Stockholm SE-171 76,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Clarelin","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic and Vascular Surgery, Lund University and Skane University Hospital , Lund SE-221 85,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"H\u00f6glund","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Sahlgrenska University Hospital , Gothenburg S-413 45,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5652-8774","authenticated-orcid":false,"given":"Michael","family":"Dismorr","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm SE-171 76,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5786-864X","authenticated-orcid":false,"given":"Shahab","family":"Nozohoor","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic and Vascular Surgery, Lund University and Skane University Hospital , Lund SE-221 85,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2356-2295","authenticated-orcid":false,"given":"Anders","family":"Jeppsson","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Sahlgrenska University Hospital , Gothenburg S-413 45,","place":["Sweden"]},{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy , Gothenburg S-413 45,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8124-5864","authenticated-orcid":false,"given":"Anna","family":"Damlin","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm SE-171 76,","place":["Sweden"]},{"name":"Department of Cardiology, Karolinska University Hospital , Stockholm SE-171 76,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3427-9455","authenticated-orcid":false,"given":"Anders","family":"Franco-Cereceda","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Karolinska University Hospital , Stockholm SE-171 76,","place":["Sweden"]},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm SE-171 76,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-0263","authenticated-orcid":false,"given":"Ulrik","family":"Sartipy","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Karolinska University Hospital , Stockholm SE-171 76,","place":["Sweden"]},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm SE-171 76,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5352-5132","authenticated-orcid":false,"given":"Magnus","family":"Dal\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Karolinska University Hospital , Stockholm SE-171 76,","place":["Sweden"]},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm SE-171 76,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"2026010610231209800_ezaf469-B1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/14779072.2021.1924676","article-title":"Increased utilization of bioprosthetic aortic valve technology: trends, drivers, controversies and future directions","volume":"19","author":"Qi","year":"2021","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026010610231209800_ezaf469-B2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(16)32381-9","article-title":"Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble","volume":"389","author":"Kontis","year":"2017","journal-title":"Lancet"},{"key":"2026010610231209800_ezaf469-B3","first-page":"695","article-title":"European multicenter study with the soprano valve for aortic valve replacement: one-year clinical experience and hemodynamic data","volume":"20","author":"Fischlein","year":"2011","journal-title":"J Heart Valve Dis"},{"key":"2026010610231209800_ezaf469-B4","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.athoracsur.2007.12.069","article-title":"Influence of prosthesis-patient mismatch on diastolic heart failure after aortic valve replacement","volume":"85","author":"Nozohoor","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2026010610231209800_ezaf469-B5","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1161\/CIRCULATIONAHA.109.844332","article-title":"The complete supraannular concept: in vivo hemodynamics of bovine and porcine aortic bioprostheses","volume":"120","author":"Ruzicka","year":"2009","journal-title":"Circulation"},{"key":"2026010610231209800_ezaf469-B6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.117.030729","article-title":"Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves","volume":"137","author":"Dvir","year":"2018","journal-title":"Circulation"},{"key":"2026010610231209800_ezaf469-B7","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/ejcts\/ezv432","article-title":"Durability after aortic valve replacement with the mitroflow versus the perimount pericardial bioprosthesis: a single-Centre experience in 2393 patients","volume":"49","author":"Nielsen","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026010610231209800_ezaf469-B8","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.114.010400","article-title":"Early structural valve deterioration of mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients","volume":"130","author":"S\u00e9nage","year":"2014","journal-title":"Circulation"},{"key":"2026010610231209800_ezaf469-B9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.athoracsur.2019.06.032","article-title":"Early structural valve degeneration of trifecta bioprosthesis","volume":"109","author":"Fukuhara","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"2026010610231209800_ezaf469-B10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ejcts\/ezx321","article-title":"Structural valve deterioration in the mitroflow biological heart valve prosthesis","volume":"53","author":"Issa","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026010610231209800_ezaf469-B11","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1111\/jocs.15972","article-title":"Trifecta versus perimount bioprosthesis for surgical aortic valve replacement; systematic review and meta-analysis","volume":"36","author":"Yokoyama","year":"2021","journal-title":"J Card Surg"},{"key":"2026010610231209800_ezaf469-B12","doi-asserted-by":"crossref","first-page":"e220962","DOI":"10.1001\/jamanetworkopen.2022.0962","article-title":"Comparison of long-term performance of bioprosthetic aortic valves in Sweden from 2003 to 2018","volume":"5","author":"Persson","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026010610231209800_ezaf469-B13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2026010610231209800_ezaf469-B14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/icvts\/ivy030","article-title":"Validity of the swedish cardiac surgery registry","volume":"27","author":"Vikholm","year":"2018","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2026010610231209800_ezaf469-B15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"2026010610231209800_ezaf469-B16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"2026010610231209800_ezaf469-B17","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026010610231209800_ezaf469-B18","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.athoracsur.2006.07.064","article-title":"Results of aortic valve replacement with a new supra-annular pericardial stented bioprosthesis","volume":"82","author":"Pavoni","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"2026010610231209800_ezaf469-B19","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.athoracsur.2014.10.070","article-title":"Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants","volume":"99","author":"Johnston","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"2026010610231209800_ezaf469-B20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.xjon.2022.05.008","article-title":"Durability of a bovine pericardial aortic bioprosthesis based on valve academic research consortium-3 echocardiographic criteria","volume":"11","author":"Kermen","year":"2022","journal-title":"JTCVS Open"},{"key":"2026010610231209800_ezaf469-B21","doi-asserted-by":"crossref","first-page":"100359","DOI":"10.1016\/j.jacadv.2023.100359","article-title":"Aortic valve replacement with mechanical valves vs perimount bioprostheses in 50- to 69-year-old patients","volume":"2","author":"Lu","year":"2023","journal-title":"JACC Adv"},{"key":"2026010610231209800_ezaf469-B22","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jtcvs.2022.10.023","article-title":"Ten-year clinical and echocardiographic follow-up of third-generation biological prostheses in the aortic position","volume":"167","author":"Francica","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026010610231209800_ezaf469-B23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1556984519858020","article-title":"Valve-in-valve TAVR: state-of-the-art review","volume":"14","author":"Edelman","year":"2019","journal-title":"Innovations (Phila)"},{"key":"2026010610231209800_ezaf469-B24","doi-asserted-by":"crossref","first-page":"e005481","DOI":"10.1161\/CIRCOUTCOMES.118.005481","article-title":"Bioprosthetic aortic valve replacement in nonelderly adults: a systematic review, Meta-Analysis, microsimulation","volume":"12","author":"Etnel","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026010610231209800_ezaf469-B25","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jacc.2020.08.049","article-title":"Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER-2 trial","volume":"76","author":"Pibarot","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026010610231209800_ezaf469-B26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jtcvs.2018.01.099","article-title":"A novel tissue treatment to reduce mineralization of bovine pericardial heart valves","volume":"156","author":"Meuris","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026010610231209800_ezaf469-B27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jacc.2019.04.053","article-title":"Loss in life expectancy after surgical aortic valve replacement: SWEDEHEART study","volume":"74","author":"Glaser","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026010610231209800_ezaf469-B28","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1001\/jama.2021.2133","article-title":"Transcatheter treatment of valvular heart disease: a review","volume":"325","author":"Davidson","year":"2021","journal-title":"JAMA"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezaf469\/66106865\/ezaf469.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/68\/1\/ezaf469\/66106865\/ezaf469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/68\/1\/ezaf469\/66106865\/ezaf469.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:32:30Z","timestamp":1767713550000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezaf469\/8402066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezaf469","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"type":"print","value":"1010-7940"},{"type":"electronic","value":"1873-734X"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,22]]},"article-number":"ezaf469"}}